We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Infective Endocarditis of Trans-Catheter Aortic Valve Implantation: Explanation of TAVI and Surgical Bioprosthetic Aortic Valve Replacement.
- Authors
Mubarak, Yasser Shaban
- Abstract
Trans-catheter Aortic Valve Implantation (TAVI) is preferred in high surgical risk patients with severe aortic stenosis (AS), especially bicuspid aortic valve (BAV), over surgical aortic valve replacement (SAVR) because it is less invasive, does not require cardiopulmonary bypass (CPB), and less morbidity. TAVI has been performed using either balloon expandable SAPIEN (Edwards Lifesciences, Irvine, CA) or self-expanding Core-Valve (Medtronic, Minneapolis, MN). Patients experienced a TAVI complication and were then subsequently reconsidered for SAVR. TAVI grows with advanced time and technology. fortunately, its complications may occur that require SAVR.
- Subjects
IRVINE (Calif.); MINNEAPOLIS (Minn.); AORTIC valve transplantation; AORTIC valve; INFECTIVE endocarditis; HEART valve prosthesis implantation; EDWARDS Lifesciences Corp.; BIOPROSTHETIC heart valves; MITRAL valve; CARDIOPULMONARY bypass
- Publication
Journal of Cardio-Thoracic Medicine, 2023, Vol 11, Issue 4, p1270
- ISSN
2345-2447
- Publication type
Article
- DOI
10.22038/jctm.2023.76472.1436